UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Successful treatment of Netherton syndrome with ustekinumab in a 15‐year‐old girl

British journal of dermatology (1951), 2020-07, Vol.183 (1), p.165-167

2020

Volltextzugriff (PDF)

Secukinumab Therapy for Netherton Syndrome

JAMA dermatology (Chicago, Ill.), 2020-08, Vol.156 (8), p.907

2020

Volltextzugriff (PDF)

Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling

Journal of the European Academy of Dermatology and Venereology, 2021-02, Vol.35 (2), p.e152-e155

2021

Volltextzugriff (PDF)

Treatment of Netherton Syndrome With Abrocitinib

JAMA dermatology (Chicago, Ill.), 2023-07, Vol.159 (7), p.791

2023

Volltextzugriff (PDF)

Outcomes of Systemic Treatment in Children and Adults With Netherton Syndrome: A Systematic Review

Frontiers in immunology, 2022-03, Vol.13, p.864449-864449

2022

Volltextzugriff (PDF)

Successful treatment of Netherton syndrome with dupilumab: A case report and review of the literature

Journal of dermatology, 2022-01, Vol.49 (1), p.165-167

2022

Volltextzugriff (PDF)

Netherton syndrome: Temporary response to dupilumab

Pediatric dermatology, 2020-11, Vol.37 (6), p.1210-1211

2020

Volltextzugriff (PDF)

Long‐term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature

Australasian journal of dermatology, 2023-05, Vol.64 (2), p.272-277

2023

Volltextzugriff (PDF)

Multidimensional response of Dupilumab in a child affected by Netherton syndrome: Improvement of trichorrhexis invaginata

Pediatric allergy and immunology, 2023-07, Vol.34 (7), p.e13997-n/a

2023

Volltextzugriff (PDF)

Dupilumab improves clinical symptoms in children with Netherton syndrome by suppressing Th2-mediated inflammation

Frontiers in immunology, 2022-12, Vol.13, p.1054422

2022

Volltextzugriff (PDF)

Cocktails of KLK5 Protease Inhibitors and Anti-TNFα Therapeutics: an Effective Treatment for Netherton Syndrome

Journal of clinical immunology, 2022-04, Vol.42 (3), p.597-605

2022

Volltextzugriff (PDF)

Successful infliximab treatment in siblings with Netherton syndrome: Unveiling a novel SPINK5 gene variant and literature review

Australasian journal of dermatology, 2024-05, Vol.65 (3), p.e45-e49

2024

Volltextzugriff (PDF)

Treatment of Netherton syndrome with dupilumab

Journal der Deutschen Dermatologischen Gesellschaft, 2022-12, Vol.20 (12), p.1636-1640

2022

Volltextzugriff (PDF)

Secukinumab for Netherton syndrome: a Malaysian experience

Clinical and experimental dermatology, 2023-11, Vol.48 (12), p.1366-1369

2023

Volltextzugriff (PDF)

Ustekinumab therapy for Netherton syndrome

Journal of dermatology, 2023-04, Vol.50 (4), p.494-499

2023

Volltextzugriff (PDF)

LEKTI domains D6, D7 and D8+9 serve as substrates for transglutaminase 1: implications for targeted therapy of Netherton syndrome

British journal of dermatology (1951), 2019-11, Vol.181 (5), p.999-1008

2019

Volltextzugriff (PDF)

Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series

Dermatology (Basel), 2023-01, Vol.239 (1), p.72-80

2023

Volltextzugriff (PDF)

Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold - A Potential Therapeutic Intervention for Skin Diseases

PloS one, 2016-11, Vol.11 (11), p.e0166268-e0166268

2016

Volltextzugriff (PDF)

Infliximab Infusions for Netherton Syndrome: Sustained Clinical Improvement Correlates with a Reduction of Thymic Stromal Lymphopoietin Levels in the Skin

Journal of investigative dermatology, 2011-09, Vol.131 (9), p.1947-1950

2011

Volltextzugriff (PDF)

Infliximab therapy in an infant with Netherton syndrome

Pediatric dermatology, 2021-05, Vol.38 (3), p.714-716

2021

Volltextzugriff (PDF)

Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature

International journal of immunopathology and pharmacology, 2023-01, Vol.37, p.3946320231172881-3946320231172881

2023

Volltextzugriff (PDF)

Treatment of ichthyosis and hypernatremia in a patient with Netherton syndrome with a SPINK5 c.153delT mutation using kallikrein inhibiting ointment

International journal of dermatology, 2017-01, Vol.56 (1), p.106-108

2017

Volltextzugriff (PDF)

A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels

Immunopharmacology and immunotoxicology, 2016-03, Vol.38 (2), p.162-166

Yalcin, Arzu Didem

2016

Volltextzugriff (PDF)

Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome

Bioorganic & medicinal chemistry letters, 2019-03, Vol.29 (6), p.821-825

2019

Volltextzugriff (PDF)

Journal club Update on systemic therapies in paediatric dermatology

EJD. European journal of dermatology, 2021-10, Vol.31 (5), p.672-675

2021

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(50)
Buchkapitel
(1)

Sprache

Englisch
(50)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Successful treatment of Netherton syndrome with ustekinumab in a 15‐year‐old girl

Secukinumab Therapy for Netherton Syndrome

Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling

Treatment of Netherton Syndrome With Abrocitinib

Outcomes of Systemic Treatment in Children and Adults With Netherton Syndrome: A Systematic Review

Successful treatment of Netherton syndrome with dupilumab: A case report and review of the literature

Netherton syndrome: Temporary response to dupilumab

Long‐term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature

Multidimensional response of Dupilumab in a child affected by Netherton syndrome: Improvement of trichorrhexis invaginata

Dupilumab improves clinical symptoms in children with Netherton syndrome by suppressing Th2-mediated inflammation

Cocktails of KLK5 Protease Inhibitors and Anti-TNFα Therapeutics: an Effective Treatment for Netherton Syndrome

Successful infliximab treatment in siblings with Netherton syndrome: Unveiling a novel SPINK5 gene variant and literature review

Treatment of Netherton syndrome with dupilumab

Secukinumab for Netherton syndrome: a Malaysian experience

Ustekinumab therapy for Netherton syndrome

LEKTI domains D6, D7 and D8+9 serve as substrates for transglutaminase 1: implications for targeted therapy of Netherton syndrome

Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series

Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold - A Potential Therapeutic Intervention for Skin Diseases

Infliximab Infusions for Netherton Syndrome: Sustained Clinical Improvement Correlates with a Reduction of Thymic Stromal Lymphopoietin Levels in the Skin

Infliximab therapy in an infant with Netherton syndrome

Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature

Treatment of ichthyosis and hypernatremia in a patient with Netherton syndrome with a SPINK5 c.153delT mutation using kallikrein inhibiting ointment

A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels

Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome

Journal club Update on systemic therapies in paediatric dermatology

Suchergebnisse filtern